Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone in Primary Aldosteronism
NCT06381323Phase 4Completed
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Mar 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of finerenone in primary aldosteronism (PA), sponsored by Nanjing Drum-Tower Hospital. Started Mar 2024; status: completed.
02
Drugs
finerenone
03
Conditions
primary aldosteronism (PA)
Beyond the preview
Go deeper on NCT06381323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06381323.